The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
Following a year of growth, healthtech startup My Intelligent Machines raises $5 million (BETAKIT)
CEO Sarah Jenna told BetaKit a “big angel” investor also participated in the round but declined to disclose the name.
Industry Insights: Selling into Financial Institutions and Regulated Enterprises
The art and science behind enterprise sales is complex, particularly when selling into heavily regulated industries. Join our panel of industry leaders who will share their insights, strategies for success and lessons learned.
Join us: Wednesday April 21, 2021 at 2:00PM EST
Microsoft’s Nuance gambit shows healthcare is shaping up as next tech battleground (WALL STREET JOURNAL)
Microsoft Corp.’s $16 billion deal for Nuance Communications Inc. is the latest sign that the next battleground for technology giants will be in healthcare, an industry whose need to embrace data and software was underscored by the pandemic.
Biotech R&D startup Benchling hits $4 billion valuation as the company starts laying groundwork for an IPO (FORBES)
That valuation—nearly five times what it was worth last May—comes as the company raised $200 million led by Sequoia Capital Global Equities.
In its quest to advance AI, Facebook is leaning into medical research (FAST COMPANY)
The company has developed an open-source framework for predicting how different treatments will affect individual cells.
BetaKit Live: Diversity in Cybersecurity (BETAKIT)
Wednesday, April 21, BetaKit is proud to present a BetaKit Live panel in partnership with Microsoft Canada focused on this important conversation: What needs to be done to build and support a diverse cybersecurity ecosystem in Canada?
Better Therapeutics plans to go public through SPAC merger (MED CITY NEWS)
The company is currently running a pivotal study to see if its app-based program could be used as a treatment for type 2 diabetes.
Nicoya promised additional funding from federal government to develop COVID-19 test (BETAKIT)
Arjun Sudarsan, Nicoya’s CTO, claims the startup’s platform-based approach “will help prepare the world for viral outbreaks beyond SARS-CoV-2.”
SoftBank leads $220 million funding for AI home gym maker Tempo (BNN BLOOMBERG)
Tempo’s valuation has more than tripled from the $250 million the San Francisco-based company was ascribed when it last raised capital in 2020.
Six ways startups can prepare for financial instability before it happens (BETAKIT)
Xero Canada Country Manager Faye Pang shares her top six tips for what small businesses can do to prepare for financial instability.
C2i genomics secures $100M note to detect tiny traces of cancer (CRUNCHBASE)
The company aims to help patients avoid unnecessary overtreatment with toxic chemotherapy or radiation, as well as to prevent them from going without treatment while cancer quietly grows and metastasizes.
Dear Canadian founders, your time is now! (BETAKIT)
Damien Steel, Managing Partner and Head of Ventures at OMERS Ventures, shares his thoughts on why there’s never been a better time to be a Canadian founder.
Memic raises $96M for its robot-assisted surgery platform (TECHCRUNCH)
The company plans to use the new funding to commercialize its platform in the U.S. and expand its marketing and sales efforts outside of the U.S.
Peloton’s ‘revolutionary’ technology faces test in patent wars (BNN BLOOMBERG)
Most analysts have remained bullish even as Peloton’s stock has slid 21 per cent this year with the end of pandemic lockdowns – and while the U.S. CPSC has warned consumers to stop using Peloton’s Tread+ treadmill.
